3 years ago

Current Status of Point-of-Care Testing for Human Immunodeficiency Virus Drug Resistance.

Anubhav Tripathi, Ruth M Kanthula, Horacio A Duarte, Barry Lutz, Ingrid A Beck, Chunfu Yang, James Lai, Michael H Chung, Shanmugam Saravanan, Iain J MacLeod, Rami Kantor, Lisa M Frenkel, Guoqing Zhang, Nuttada Panpradist
Healthcare delivery has advanced due to the implementation of point-of-care testing, which is often performed within minutes to hours in minimally equipped laboratories or at home. Technologic advances are leading to point-of-care kits that incorporate nucleic acid-based assays, including polymerase chain reaction, isothermal amplification, ligation, and hybridization reactions. As a limited number of single-nucleotide polymorphisms are associated with clinically significant human immunodeficiency virus (HIV) drug resistance, assays to detect these mutations have been developed. Early versions of these assays have been used in research. This review summarizes the principles underlying each assay and discusses strategic needs for their incorporation into the management of HIV infection.

Publisher URL: http://doi.org/10.1093/infdis/jix413

DOI: 10.1093/infdis/jix413

You might also like
Never Miss Important Research

Researcher is an app designed by academics, for academics. Create a personalised feed in two minutes.
Choose from over 15,000 academics journals covering ten research areas then let Researcher deliver you papers tailored to your interests each day.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.